Udager AM, et al. – The clinicopathologic and molecular features of melanoma originating from gynecologic sites (MOGS) were examined. With the poor long–term clinical outcome, non–vulvar MOGS were determined as aggressive tumors. Results reported that few targeted therapeutic options were currently available to patients with MOGS.